Repeated transfusions of genetically modified cells are required in SCID patients and in enzyme repl

English

Gujarati

Hindi

10.Biotechnology and its Application

normal

Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

A

Transfused cells have a limited life span

B

Introduced gene has been mutated

C

The enzyme required is degraded after $20\; days$ of transfusion

D

Both $(a)$ and $(c)$

Solution

$SCID$ is caused due to defect in gene for adenosine deaminase.

Standard 12

Biology

Share

Similar Questions

Which of the following may be considered as an application of biotechnology?

normal

Infestation by tobacco budworm and armyworm is prevented by Bt toxin. These insects belong to order

normal

Biotechnology is the modern branch of biology which deals with

normal

Lal Bahadur Shastri biotechnological centre is in

normal

Gene therapy is an attempt to correct a genetic defect by providing a normal gene into the individual. By this the normal function can be restored. An alternate method would be to provide the gene product (protein/enzyme) known as enzyme replacement therapy, which would also restore the function. Which in your opinion is a better option ? Give reason for your answer.

normal